Subsequent technology sequencing reveals a novel pathogenic variant within the ATMgene
Introduction: Ataxia telangiectasia (A-T) is a unusual autosomal recessive multisystemic sickness. Victims with the A-T syndrome present a broad spectrum of sickness phenotypes. The ATM (ataxia telangiectasia mutated) gene, the one causative gene for A-T.
Methodology: A affected individual of Persian origin presenting with typical A-T was referred to our genetics center for specialised genetic counseling and testing. Centered next-generation sequencing (NGS) was utilized. Sanger sequencing was used to substantiate the candidate variant. Modeling was carried out using the SWISS-MODEL server.Outcomes: A homozygous stop-gain variant c.829G > T (p.E277*) was found throughout the ATM gene. This variant was confirmed by Sanger sequencing and modeling of native building and truncated building was carried out.
Conclusion: Up to now, just a few pathogenic variants of the ATM gene have been reported from the Iranian inhabitants. The discovering has implications in molecular diagnostic for A-T in Iran.
Alpha-bungarotoxin, CF405s
00002-100ug
Biotium
100uG
EUR 161
Alpha-bungarotoxin, CF680r
9-00003
Biotium
Alpha-bungarotoxin, CF680r
9-00003
Biotium
Alpha-bungarotoxin, CF640r
9-00004
Biotium
Alpha-bungarotoxin, CF640r
9-00004
Biotium
Alpha-bungarotoxin, CF488a
9-00005
Biotium
Alpha-bungarotoxin CF488a
9-00005
Biotium
Alpha-bungarotoxin, CF568
9-00006
Biotium
Alpha-bungarotoxin, CF568
9-00006
Biotium
Alpha-bungarotoxin, CF594
9-00007
Biotium
Alpha-bungarotoxin CF594
9-00007
Biotium
Alpha-bungarotoxin, CF633
9-00009
Biotium
Alpha-bungarotoxin, CF633
9-00009
Biotium
Alpha-bungarotoxin
00010-1
Biotium
1MG
EUR 168
Fluorescein-Alpha-bungarotoxin
00011
Biotium
500uG
EUR 367
Tetramethylrhodamine-Alpha-bungarotoxin
00012
Biotium
500uG
EUR 383
Fluorescein-alpha-bungarotoxin: (10x50ug)
00013
Biotium
10ST
EUR 417
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug)
00014
Biotium
10ST
EUR 466
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug)
00015
Biotium
500uG
EUR 466
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug)
00016
Biotium
10ST
EUR 523
Biotin-xx-a-bungarotoxin
00017
Biotium
500uG
EUR 433
Alpha-Bungarotoxin, CF555 conjugate
9-00018
Biotium
Alpha-Bungarotoxin, CF555 conjugate
9-00018
Biotium
Biotin-cAMP, diisopropylethylammonium salt:
00020
Biotium
1MG
EUR 314
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug)
00020-1
Biotium
20ST
EUR 418
Biotin-cGMP, diisopropylethylammonium salt:
00021
Biotium
1MG
EUR 344
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug)
00021-1
Biotium
20ST
EUR 448
Cyanine 644-cAMP:
00022
Biotium
1MG
EUR 491
Cyanine 644-cAMP: (20x50ug)
00022-1
Biotium
20ST
EUR 625
Fluorescein Methotrexate, triammonium salt:
00023
Biotium
1MG
EUR 281
Staurosporine
00025
Biotium
100uG
EUR 139
Alpha-bungarotoxin, CF543
00026
Biotium
500uG
EUR 494
Rhodamine phalloidin 300u
00027
Biotium
300
EUR 345
Biotin-xx-phalloidin
00028
Biotium
100U
EUR 428
Fluorescein-phalloidin
00030
Biotium
300U
EUR 345
Rhodamine 110 phalloidin
00032
Biotium
300ST
EUR 345
Sulforhodamine 101 (Texas-Red) Phalloidin
00033
Biotium
300EU
EUR 345
Phalloidin, CF405M
00034
Biotium
300U
EUR 442
Phalloidin, CF405M
00034-T
Biotium
50U
EUR 133
CF488A-cAMP
00036
Biotium
100ug
EUR 172
CF640R-cAMP
00037
Biotium
100ug
EUR 172
Phalloidin, CF555
00040
Biotium
300U
EUR 442
Phalloidin, CF555
00040-T
Biotium
50U
EUR 133
Phalloidin, CF647
00041
Biotium
300U
EUR 442
Phalloidin, CF647
00041-T
Biotium
50U
EUR 133
Phalloidin, CF488A
00042
Biotium
300U
EUR 442
Phalloidin, CF488A
00042-T
Biotium
50U
EUR 133
Phalloidin, CF543
00043
Biotium
300U
EUR 442
Phalloidin, CF543
00043-T
Biotium
50U
EUR 133
Phalloidin, CF568
00044
Biotium
300U
EUR 442
Phalloidin, CF568
00044-T
Biotium
50U
EUR 133
Phalloidin, CF594
00045
Biotium
300U
EUR 442
Phalloidin, CF594
00045-T
Biotium
50U
EUR 133
Phalloidin, CF633
00046
Biotium
300U
EUR 442
Phalloidin, CF633
00046-T
Biotium
50U
EUR 133
Phalloidin, CF660R
00047
Biotium
300U
EUR 442
Phalloidin, CF660R
00047-T
Biotium
50U
EUR 133
Phalloidin, CF680R
00048
Biotium
300U
EUR 466
Phalloidin, CF680R
00048-T
Biotium
50U
EUR 133
Phalloidin, CF350
00049
Biotium
300U
EUR 442
Phalloidin, CF350
00049-T
Biotium
50U
EUR 133
Phalloidin, CF640R
00050
Biotium
300U
EUR 442
Phalloidin, CF640R
00050-T
Biotium
50U
EUR 133
Phalloidin, CF532
00051
Biotium
300U
EUR 442
Phalloidin, CF532
00051-T
Biotium
50U
EUR 133
Phalloidin, CF660C
00052
Biotium
300U
EUR 442
Phalloidin, CF660C
00052-T
Biotium
50U
EUR 133
Phalloidin, CF680
00053
Biotium
300U
EUR 466
Phalloidin, CF680
00053-T
Biotium
50U
EUR 147
Phalloidin, CF430
00054
Biotium
300U
EUR 449
Phalloidin, CF430
00054-T
Biotium
50U
EUR 139
Phalloidin, CF440
00055
Biotium
300U
EUR 449
Phalloidin, CF440
00055-T
Biotium
50U
EUR 139
Cholera Toxin Subunit B, CF488A conjugate
00070
Biotium
100ug
EUR 261
Cholera Toxin Subunit B, CF568 conjugate
00071
Biotium
100ug
EUR 261
Cholera Toxin Subunit B, CF594 conjugate
00072
Biotium
100ug
EUR 261
Cholera Toxin Subunit B, CF640R conjugate
00073
Biotium
100ug
EUR 264
Cholera Toxin Subunit B, CF532 conjugate
00074
Biotium
100ug
EUR 264
Cholera Toxin Subunit B, CF543 conjugate
00075
Biotium
100ug
EUR 264
Cholera Toxin Subunit B, CF620R conjugate
00076
Biotium
100ug
EUR 264
Cholera Toxin Subunit B, CF633 conjugate
00077
Biotium
100ug
EUR 264
Cholera Toxin Subunit B, CF660R conjugate
00078
Biotium
100ug
EUR 264
Cholera Toxin Subunit B, CF680R conjugate
00079
Biotium
100ug
EUR 282
Human Transferrin, CF488A conjugate
00081
Biotium
1mg
EUR 149
Human Transferrin, CF543 conjugate
00082
Biotium
1mg
EUR 149
Human Transferrin, CF568 conjugate
00083
Biotium
1mg
EUR 149
Human Transferrin, CF594 conjugate
00084
Biotium
1mg
EUR 149
Human Transferrin, CF640R conjugate
00085
Biotium
1mg
EUR 149
Human Transferrin, CF680R conjugate
00086
Biotium
1mg
EUR 149
Human Transferrin, CF750 conjugate
00087
Biotium
1mg
EUR 155
HIV-1 tat recombinant antigen
00110-V-01mg
Virogen
0,1 mg
EUR 267.5
HIV-1 tat recombinant antigen
00110-V-1000ug
Virogen
1000 ug
EUR 1282.5
HIV-1 GAG P24 Recombinant Antigen
00111-V-01mg
Virogen
0,1 mg
EUR 267.5
HIV-1 GAG P24 Recombinant Antigen
00111-V-1000ug
Virogen
1000 ug
EUR 1282.5
HIV-1 nef recombinant antigen
00112-V-01mg
Virogen
0,1 mg
EUR 267.5
HIV-1 nef recombinant antigen
00112-V-1000ug
Virogen
1000 ug
EUR 1282.5
HIV-1 env gp41 recombinant antigen
00113-V-01mg
Virogen
0,1 mg
EUR 267.5
HIV-1 env gp41 recombinant antigen
00113-V-1000ug
Virogen
1000 ug
EUR 1282.5
HIV-2 GP 36 Recombinant Antigen
00114-V-01mg
Virogen
0,1 mg
EUR 267.5
HIV-2 GP 36 Recombinant Antigen
00114-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV core recombinant antigen
00115-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV core recombinant antigen
00115-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV core recombinant antigen, Biotin conjugate
00115-V-B-01mg
Virogen
0,1 mg
EUR 267.5
HCV core recombinant antigen, Biotin conjugate
00115-V-B-1000ug
Virogen
1000 ug
EUR 1282.5
HCV core recombinant antigen, FITC conjugate
00115-V-F-01mg
Virogen
0,1 mg
EUR 267.5
HCV core recombinant antigen, FITC conjugate
00115-V-F-1000ug
Virogen
1000 ug
EUR 1282.5
HCV core recombinant antigen, Rhodamine
00115-V-R-01mg
Virogen
0,1 mg
EUR 267.5
HCV core recombinant antigen, Rhodamine
00115-V-R-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS4 recombinant antigen NS4a+b
00116-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS4 recombinant antigen NS4a+b
00116-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS4 recombinant antigen NS4a+b, Biotin
00116-V-B-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS4 recombinant antigen NS4a+b, Biotin
00116-V-B-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS4 recombinant antigen NS4a+b, FITC
00116-V-F-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS4 recombinant antigen NS4a+b, FITC
00116-V-F-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS4 recombinant antigen NS4a+b, Rhodamine
00116-V-R-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS4 recombinant antigen NS4a+b, Rhodamine
00116-V-R-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS3 recombinant antigen
00117-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS3 recombinant antigen
00117-V-1000ug
Virogen
1000 ug
EUR 1282.5
HBV core recombinant antigen
00120-V-01mg
Virogen
0,1 mg
EUR 267.5
HBV core recombinant antigen
00120-V-1000ug
Virogen
1000 ug
EUR 1282.5
HBV core recombinant antigen, Delta
00121-V-01mg
Virogen
0,1 mg
EUR 267.5
HBV core recombinant antigen, Delta
00121-V-1000ug
Virogen
1000 ug
EUR 1282.5
HBV surface recombinant antigen HBsAg
00122-V-01mg
Virogen
0,1 mg
EUR 267.5
HBV surface recombinant antigen HBsAg
00122-V-1000ug
Virogen
1000 ug
EUR 1282.5
HBV surface recombinant antigen HBsAg antigen
00123-V-01mg
Virogen
0,1 mg
EUR 267.5
HBV surface recombinant antigen HBsAg antigen
00123-V-1000ug
Virogen
1000 ug
EUR 1282.5
HBV surface recombinant antigen HBsAg antigen
00124-V-01mg
Virogen
0,1 mg
EUR 267.5
HBV surface recombinant antigen HBsAg antigen
00124-V-1000ug
Virogen
1000 ug
EUR 1282.5
HEV (Birma) ORF2 recombinant antigen
00131-V-01mg
Virogen
0,1 mg
EUR 267.5
HEV (Birma) ORF2 recombinant antigen
00131-V-1000ug
Virogen
1000 ug
EUR 1282.5
HEV (Birma) ORF2 recombinant antigen
00132-V-01mg
Virogen
0,1 mg
EUR 267.5
HEV (Birma) ORF2 recombinant antigen
00132-V-1000ug
Virogen
1000 ug
EUR 1282.5
AA 403-461 HEV Birma ORF2 Recombinant Antigen
00133-V-01mg
Virogen
0,1 mg
EUR 267.5
AA 403-461 HEV Birma ORF2 Recombinant Antigen
00133-V-1000ug
Virogen
1000 ug
EUR 1282.5
T, Pallidum recombinant antigen p15
00141-V-01mg
Virogen
0,1 mg
EUR 267.5
T, Pallidum recombinant antigen p15
00141-V-1000ug
Virogen
1000 ug
EUR 1282.5
T, Pallidum recombinant antigen p17
00142-V-01mg
Virogen
0,1 mg
EUR 267.5
T, Pallidum recombinant antigen p17
00142-V-1000ug
Virogen
1000 ug
EUR 1282.5
T, Pallidum recombinant antigen p45
00143-V-01mg
Virogen
0,1 mg
EUR 267.5
T, Pallidum recombinant antigen p45
00143-V-1000ug
Virogen
1000 ug
EUR 1282.5
T, pallidum recombinant antigen TmpA
00144-V-01mg
Virogen
0,1 mg
EUR 267.5
T, pallidum recombinant antigen TmpA
00144-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV core 2-119aa recombinant antigen
00150-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV core 2-119aa recombinant antigen
00150-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV Core 24 Antigen
00151-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV Core 24 Antigen
00151-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV core recombinant antigen
00152-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV core recombinant antigen
00152-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS3 1192-1456 aa Recombinant Antigen
00153-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS3 1192-1456 aa Recombinant Antigen
00153-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS3 1359-1456aa antigen
00154-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS3 1359-1456aa antigen
00154-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS4 mosaic recombinant antigen
00155-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS4 mosaic recombinant antigen
00155-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS4 1916-1947aa recombinant antigen
00156-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS4 1916-1947aa recombinant antigen
00156-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS5 2061-2302aa recombinant antigen
00157-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS5 2061-2302aa recombinant antigen
00157-V-1000ug
Virogen
1000 ug
EUR 1282.5
HCV NS5 2212-2313aa recombinant antigen
00158-V-01mg
Virogen
0,1 mg
EUR 267.5
HCV NS5 2212-2313aa recombinant antigen
00158-V-1000ug
Virogen
1000 ug
EUR 1282.5
HAV VP1-P2A recombinant antigen
00159-V-01mg
Virogen
0,1 mg
EUR 267.5
HAV VP1-P2A recombinant antigen
00159-V-1000ug
Virogen
1000 ug
EUR 1282.5
HAV VP4-VP2 recombinant antigen
00160-V-01mg
Virogen
0,1 mg
EUR 267.5
HAV VP4-VP2 recombinant antigen
00160-V-1000ug
Virogen
1000 ug
EUR 1282.5
HAV P2C-P3A recombinant antigen
00161-V-01mg
Virogen
0,1 mg
EUR 267.5
Familial dilated cardiomyopathy introduced on by a novel variant throughout the Lamin A/C gene: a case report
Background: Familial dilated cardiomyopathy (FDCM) is generally inherited as an autosomal dominant trait. The Lamin A/C (LMNA) gene variants have been acknowledged to be associated to DCM, conductive system issues, form 2 Emery-Dreifuss muscular dystrophy and numerous different completely different issues. Proper right here, we reported a novel variant throughout the LMNA gene that’s prone to be related to FDCM.
Case presentation: A 30-year-old youthful man was hospitalized for chest tightness, extreme fatigue, palpitation and impaired train tolerance. He had scientific traits along with cardiac dilatation, atrial tachyarrhythmia, excessive conductive system issues, and dyskinesia of every increased limbs and the neck. Genetic sequence analysis indicated that the affected individual carried a novel c.1325 T>C heterozygous LMNA gene variant. Catheter ablation and cardiac resynchronization treatment with pacing carry out (CRT-P) have been carried out to take care of the arrhythmia.
Conclusion: The variant c.1325 T>C is a novel variant throughout the LMNA gene that has not been beforehand reported. Youthful victims with DCM, conductive system issues and skeletal myopathy should be alert to the potential for LMNA gene variant. Cardiac resynchronization treatment (CRT) is also an inexpensive choice for affected individual carrying a LMNA gene variant with third-degree atrioventricular block even when the left ventricular ejection fraction is preserved with the intention to cease the deterioration of cardiac carry out introduced on by correct ventricular pacing dependency.
Genetic analysis of children with congenital ocular anomalies in three ecological areas of Nepal: a piece II of Nepal pediatric ocular sicknesses analysis
Background: Genetic eye sicknesses symbolize a giant and heterogeneous group of childhood ocular morbidity. Specific individual sicknesses may set off numerous structural anomalies and developmental choices. Nepal Pediatric Ocular Sickness Analysis (NPODS) was a population-based epidemiological analysis carried out all through three ecological areas of Nepal to search out out the prevalence and etiology of childhood ocular morbidity and blindness. In Half II of this analysis, genetic analysis was carried out for teenagers who’ve been found to have congenital ocular anomalies.
Methodology: It was a cross sectional descriptive analysis. A whole of 10,270 kids all through three completely completely different ecological areas in Nepal (Low lands, hills, and mountains) underwent ocular examinations in NPODS. Out of 374 (3.6%) of children with ocular abnormalities, 30 have been thought-about congenital in nature. Centered genetic analysis, along with genotyping for genes explicit to presenting phenotype, was carried out for 25 kids using serum samples.
Outcomes: Out of 25 kids, 18 had important genetic outcomes. Analysis revealed one missense alteration G12411T of Zinc Finger Homeobox 4 (ZFHX4) gene in a single participant amongst 10 with congenital ptosis and one different missense variation T > C P. Y374 C of Signaling Receptor and Transporter Retinol 6 (STRA6) gene in a single participant amongst Three with microphthalmos.
Conclusion: The analysis is first of its kind from Nepal and mutant genes have been distinctive to Nepalese Inhabitants. Extra analysis of genetic parts is crucial to increased understand genetic affiliation with ocular sicknesses and conditions. This helps extra in genetic counseling and probably gene treatment to forestall blindness from these conditions.
Doxorubicin Hydrochloride |
|||
| 20-abx076623 | Abbexa |
|
|
Doxorubicin hydrochloride |
|||
| GA4969-100MG | Glentham Life Sciences | 100 mg | EUR 181 |
Doxorubicin hydrochloride |
|||
| GA4969-10MG | Glentham Life Sciences | 10 mg | EUR 78 |
Doxorubicin hydrochloride |
|||
| GA4969-25MG | Glentham Life Sciences | 25 mg | EUR 98 |
Doxorubicin hydrochloride |
|||
| GA4969-50MG | Glentham Life Sciences | 50 mg | EUR 126 |
Doxorubicin hydrochloride |
|||
| TNC00267 | ChemNorm | 20mg | Ask for price |
Doxorubicin hydrochloride USP |
|||
| D005-10MG | TOKU-E | 10 mg | EUR 166 |
Doxorubicin hydrochloride USP |
|||
| D005-25MG | TOKU-E | 25 mg | EUR 301 |
Doxorubicin Hydrochloride (Autophagy inducer) |
|||
| SIH-390-10MG | Stressmarq | 10 mg | EUR 193 |
|
Description: The substance Doxorubicin Hydrochloride is a autophagy inducer. It is synthetically produced and has a purity of >98%. The pure substance is red solid which is soluble in water (50 mM).. |
|||
Doxorubicin Hydrochloride (Autophagy inducer) |
|||
| SIH-390-50MG | Stressmarq | 50 mg | EUR 529 |
|
Description: The substance Doxorubicin Hydrochloride is a autophagy inducer. It is synthetically produced and has a purity of >98%. The pure substance is red solid which is soluble in water (50 mM).. |
|||
Erlotinib, Hydrochloride Salt |
|||
| 1588-100 | Biovision | EUR 169 | |
Erlotinib, Hydrochloride Salt |
|||
| 1588-1000 | Biovision | EUR 398 | |
Doxorubicin |
|||
| D063-100MG | TOKU-E | 100 mg | EUR 1051 |
Doxorubicin |
|||
| D063-25MG | TOKU-E | 25 mg | EUR 322 |
Doxorubicin |
|||
| HY-15142A | MedChemExpress | 100mg | EUR 215 |
Doxorubicin |
|||
| ADC-P-013 | Creative Biolabs | unit | Ask for price |
Doxorubicin |
|||
| abx188695-1g | Abbexa | 1 g | EUR 467 |
Doxorubicin |
|||
| A3966-10 | ApexBio | 10 mg | EUR 108 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Doxorubicin |
|||
| A3966-100 | ApexBio | 100 mg | EUR 235 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Doxorubicin |
|||
| A3966-25 | ApexBio | 25 mg | EUR 131 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Doxorubicin |
|||
| A3966-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 131 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Doxorubicin |
|||
| A3966-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Erlotinib, Hydrochloride Salt, >99% |
|||
| BC026-101 | GenDepot | 1g | EUR 273 |
Erlotinib, Hydrochloride Salt, >99% |
|||
| BC026-102 | GenDepot | 2g | EUR 388 |
Erlotinib, Hydrochloride Salt, >99% |
|||
| BC026-105 | GenDepot | 5g | EUR 570 |
Adriamycin (Doxorubicin) |
|||
| E1KS1208 | EnoGene | 10mg | EUR 409 |
Doxorubicin HCl |
|||
| 20-abx184016 | Abbexa |
|
|
Doxorubicin 10mM |
|||
| TG4120 | TopoGen | 0.25ml | EUR 156 |
17-DMAG, Hydrochloride Salt, >98% |
|||
| BC024-001 | GenDepot | 1mg | EUR 178 |
17-DMAG, Hydrochloride Salt, >98% |
|||
| BC024-005 | GenDepot | 5mg | EUR 286 |
17-DMAG, Hydrochloride Salt, >98% |
|||
| BC024-010 | GenDepot | 10mg | EUR 408 |
17-DMAG, Hydrochloride Salt, >98% |
|||
| BC024-025 | GenDepot | 25mg | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
| BC024-100 | GenDepot | 100mg | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
| BC024-101 | GenDepot | 1g | Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|||
| BC024-250 | GenDepot | 250mg | Ask for price |
OSU-03012, Hydrochloride Salt, >98% |
|||
| BC061-005 | GenDepot | 5mg | EUR 313 |
OSU-03012, Hydrochloride Salt, >98% |
|||
| BC061-025 | GenDepot | 25mg | EUR 529 |
Doxorubicin HCl, 100mg |
|||
| R2531-100mg | ACTGene | EUR 1300 | |
Doxorubicin HCl, 10mg |
|||
| R2531-10mg | ACTGene | EUR 197 | |
Doxorubicin (Adriamycin) HCl |
|||
| A1832-10 | ApexBio | 10 mg | EUR 125 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Doxorubicin (Adriamycin) HCl |
|||
| A1832-25 | ApexBio | 25 mg | EUR 189 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Doxorubicin (Adriamycin) HCl |
|||
| A1832-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
|||
Anti-EGFR-doxorubicin ADC |
|||
| ADC-W-600 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a linker to a doxorubicin |
|||
Anti-CD22-DIBO-doxorubicin ADC |
|||
| ADC-W-339 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-CD22 monoclonal antibody conjugated via a DIBO linker to a doxorubicin |
|||
Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC |
|||
| ADC-W-406 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a DIBO linker to a doxorubicin |
|||
Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC |
|||
| ADC-W-412 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a NGM linker to adoxorubicin |
|||
Anti-EGFR (cetuximab)-SMCC-Doxorubicin ADC |
|||
| ADC-W-504 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody (cetuximab) conjugated via a SMCC linker to Doxorubicin |
|||
Anti-EpCAM (MOC31)-hydrazone-Doxorubicin ADC |
|||
| ADC-W-581 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-EPCAM monoclonal antibody (MOC31) conjugated via a hydrazone linker to Doxorubicin |
|||
Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC |
|||
| ADC-W-423 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone cBR96) conjugated via a hydrazone linker to adoxorubicin |
|||
Anti-CD70 (clone h1F6)-β-glucuronide-doxorubicin ADC |
|||
| ADC-W-376 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-CD70 monoclonal antibody (clone h1F6) conjugated via a β-glucuronide linker to a doxorubicin |
|||
Bile salt |
|||
| BB0225 | Bio Basic | 25g | EUR 79.58 |
Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC |
|||
| ADC-W-353 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a doxorubicin propyloxazoline (DPO) |
|||
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated |
|||
| HCL-2004 | Alpha Diagnostics | 100ug | EUR 225 |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated |
|||
| HCL-2010 | Alpha Diagnostics | 100ug | EUR 213 |
Laurolitsine (hydrochloride) |
|||
| HY-N2352A | MedChemExpress | 10mg | EUR 1318 |
Tirzepatide (hydrochloride) |
|||
| HY-P1731B | MedChemExpress | 5mg | EUR 1427 |
Etelcalcetide (hydrochloride) |
|||
| HY-P1955A | MedChemExpress | 10mg | EUR 349 |
Piridocaine (hydrochloride) |
|||
| HY-U00109 | MedChemExpress | 10mg | EUR 986 |
Cyclodrine (hydrochloride) |
|||
| HY-U00139 | MedChemExpress | 5mg | EUR 601 |
Drobuline (hydrochloride) |
|||
| HY-U00149 | MedChemExpress | 5mg | EUR 877 |
Dopexamine hydrochloride |
|||
| HY-U00205 | MedChemExpress | 1mg | EUR 463 |
AE0047 Hydrochloride |
|||
| HY-U00284 | MedChemExpress | 20mg | EUR 3356 |
Bometolol Hydrochloride |
|||
| HY-U00386 | MedChemExpress | 1mg | EUR 3218 |
GSK2850163 hydrochloride |
|||
| HY-U00459B | MedChemExpress | 10mg | EUR 371 |
TCEP (hydrochloride) |
|||
| HY-W011500 | MedChemExpress | 10mM/1mL | EUR 113 |
Tulobuterol (hydrochloride) |
|||
| HY-W011733 | MedChemExpress | 500mg | EUR 199 |
MCLA hydrochloride |
|||
| HY-W013275 | MedChemExpress | 5mg | EUR 318 |
Icotinib hydrochloride |
|||
| I035-10MG | TOKU-E | 10 mg | EUR 347 |
Kasugamycin hydrochloride |
|||
| K005-10G | TOKU-E | 10 g | EUR 276 |
Kasugamycin hydrochloride |
|||
| K005-1G | TOKU-E | 1 g | EUR 86 |
Kasugamycin hydrochloride |
|||
| K005-50G | TOKU-E | 50 g | EUR 868 |
Methacycline hydrochloride |
|||
| M003-100MG | TOKU-E | 100 mg | EUR 139 |
Methacycline hydrochloride |
|||
| M003-1G | TOKU-E | 1 g | EUR 187 |
Minocycline hydrochloride |
|||
| M008-1G | TOKU-E | 1 g | EUR 347 |
Minocycline hydrochloride |
|||
| M008-500MG | TOKU-E | 500 mg | EUR 200 |
Mitoxantrone hydrochloride |
|||
| M010-50MG | TOKU-E | 50 mg | EUR 129 |
Lomefloxacin hydrochloride |
|||
| L005-1G | TOKU-E | 1 g | EUR 74 |
Lomefloxacin hydrochloride |
|||
| L005-5G | TOKU-E | 5 g | EUR 153 |
Daunorubicin hydrochloride |
|||
| D001-10MG | TOKU-E | 10 mg | EUR 119 |
Daunorubicin hydrochloride |
|||
| D001-50MG | TOKU-E | 50 mg | EUR 400 |
Difloxacin hydrochloride |
|||
| D021-1G | TOKU-E | 1 g | EUR 111 |
Difloxacin hydrochloride |
|||
| D021-5G | TOKU-E | 5 g | EUR 365 |
Demeclocycline hydrochloride |
|||
| D032-1G | TOKU-E | 1 g | EUR 174 |
Demeclocycline hydrochloride |
|||
| D032-250MG | TOKU-E | 250 mg | EUR 88 |
Demeclocycline hydrochloride |
|||
| D032-5G | TOKU-E | 5 g | EUR 539 |
Doxycycline Hydrochloride |
|||
| D065-25MG | TOKU-E | 25mg | EUR 342 |
Doxycycline Hydrochloride |
|||
| D065-5MG | TOKU-E | 5mg | EUR 119 |
Dalbavancin Hydrochloride |
|||
| D092-10MG | TOKU-E | 10mg | EUR 127 |
Dalbavancin Hydrochloride |
|||
| D092-50MG | TOKU-E | 50mg | EUR 380 |
Dimethylamine hydrochloride |
|||
| DB0410 | Bio Basic | 500g | EUR 96.98 |
Betaine hydrochloride |
|||
| BB0133 | Bio Basic | 250g | EUR 75.52 |
Benzamidine hydrochloride |
|||
| BD0076 | Bio Basic | 25g | EUR 81.32 |
Cefepime Hydrochloride |
|||
| C009-100MG | TOKU-E | 100 mg | EUR 267 |
Ceftazidime Hydrochloride |
|||
| C020-1G | TOKU-E | 1 g | EUR 622 |
Ciprofloxacin hydrochloride |
|||
| C032-25G | TOKU-E | 25 g | EUR 166 |
Ciprofloxacin hydrochloride |
|||
| C032-5G | TOKU-E | 5 g | EUR 62 |
Clindamycin Hydrochloride |
|||
| C035-100MG | TOKU-E | 100 mg | EUR 203 |
Clindamycin Hydrochloride |
|||
| C035-50MG | TOKU-E | 50 mg | EUR 127 |
